Scribd Logo
Upload

Welcome to Scribd!

  • 1 (6) - 部分2

    Uploaded by

    Ricky Chiu
    16 views1 page
    The document summarizes the status of biopharmaceutical industry in Korea, listing companies, stem cell-based products in development, target diseases, and clinical trial phases. Several companies are developing mesenchymal stem cell therapies from sources like adipose tissue, bone marrow, and cord blood to treat diseases ranging from arthritis and dementia to cancer and liver diseases. Many of these therapies are in early phases 1 or 2 of clinical trials.

    Original Description:

    Original Title

    1 (6)_部分2

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The document summarizes the status of biopharmaceutical industry in Korea, listing companies, stem cell-based products in development, target diseases, and clinical trial phases. Several companies are developing mesenchymal stem cell therapies from sources like adipose tissue, bone marrow, and cord blood to treat diseases ranging from arthritis and dementia to cancer and liver diseases. Many of these therapies are in early phases 1 or 2 of clinical trials.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    16 views1 page

    1 (6) - 部分2

    Uploaded by

    Ricky Chiu
    The document summarizes the status of biopharmaceutical industry in Korea, listing companies, stem cell-based products in development, target diseases, and clinical trial phases. Several companies are developing mesenchymal stem cell therapies from sources like adipose tissue, bone marrow, and cord blood to treat diseases ranging from arthritis and dementia to cancer and liver diseases. Many of these therapies are in early phases 1 or 2 of clinical trials.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    Korea Biomedicine Industry Association Status of BiopharmaceuticalIndustry in Korea

    Company Product Category Target disease Phase Company Product Category Target disease Phase
    Adipose cell derived Degenerative 1/2 Cord blood derived Rheumatoid
    ANL-Jointstem Auto Purestem-RA inj Allo 1
    stem cell arthritis (Completed) mesenchymal stem cell arthritis
    Adipose cell derived Embryogenic stem cell
    Jointstem-Allo Allo Osteoarthritis 1
    stem cell hES-RPE Allo derived retina epithelial Stargardt disease 1
    Adipose cell derived 1 CHA bio and cell
    ANT-SM Auto Fecal incontinence
    stem cell Diostech Embryogenic stem cell
    Senile dryform
    Adipose cell derived Complex anal hES-RPE Allo derived retina epithelial 1/2a
    ANTG-ASC Auto 2 AMD
    stem cell fissure cell
    Anterogen
    Adipose cell derived Fistula from
    ALLO-ASC Allo 1/2a
    stem cell Crohn’s disease
    Adipose cell derived Tennis elbow
    ALLO-ASC-TI Allo 1/2 Annex4 | Status of Gene Therapy Development
    stem cell (Epicondylitis)
    Support an
    Company Product Target disease Phase
    Cord blood derived unrelated
    Promostem Allo 1/2
    mesenchymal stem cell hemopoietic stem Pusan National University JX-594 Renal cell carcinoma 2a
    cell transplantation
    Kolon Life Science Tissuegene-C Degenerative arthritis 3
    Premature
    Medipost Cord blood derived
    Pneumostem Allo bronchopulmonary 2 Seropositive recipients undergoing
    mesenchymal stem cell Astellas Pharma Global
    dysplasia ASP0113 Inj. HCT (Hematopoietic Cell 3
    Development Inc.
    Transplant)
    Cord blood derived Alzheimer’s
    Neurostem Allo 1/2a VGX Internationals VGX-6150 Chronic Hepatitis B 1
    mesenchymal stem cell dementia
    Genexine HB-110 Chronic Hepatitis B 2a
    Bone marrow derived 1 Oncolys Biopharm Inc. Telomerlycin HCC 1/2
    Homeotherapy Homeo-GH Allo GVHD
    stem cell (Completed) Colon cancer with hepatic
    Recombinant
    HYNR-CS Bone marrow derived 1/2 National Cancer Center metastasis, Gastric cancer with 1
    Auto ALS Adenovirus
    HYNR-CS inj stem cell (Completed) hepatic metastasis
    Corestem Recombinant
    HYNR-CS-Allo Bone marrow derived Dong-A University Hospital Advanced HCC 1
    Allo ALS 1 Adenovirus
    HYNR-CS-Allo inj stem cell Quintiles Telomerlycin HCC 1
    Cord blood Long-term
    derived Cord blood derived follow up
    Allo Leg ischemia 1
    mesenchymal mesenchymal stem cell Genexine GX-188E Premalignancy of Cervix (CIN3) observations
    stem cell therapy from completed
    BRIC phase 2
    Cord blood derived
    Kangstembiotech Purestem-AD inj Allo Atopic dermatitis 1/2a
    mesenchymal stem cell Genexine GX-051 Head and neck cancer 1/2

    Cord blood derived Shillajen SJ-103β Hepatic carcinoma 1


    Purestem-CD inj Allo Crohn’s disease 1/2a
    mesenchymal stem cell

    10 11

    You might also like